Global Information
회사소개 | 문의 | 비교리스트

세계의 마이코플라스마 검사 시장(2020-2024년)

Global Mycoplasma Testing Market 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2020년 04월 상품 코드 635697
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 2,995,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,594,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,792,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,991,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 마이코플라스마 검사 시장(2020-2024년) Global Mycoplasma Testing Market 2020-2024
발행일 : 2020년 04월 페이지 정보 : 영문 120 Pages

세계 마이코플라스마 검사 시장은 2020-2024년간 11%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 시장 규모가 4억 4,557만 달러에 달할 것으로 예측됩니다. 바이오 의약품 연구개발 증가와 마이코플라스마 검사에 대한 재정 지원 증가, 실시간 마이코플라스마 검사 도입 확대 등에 의해 시장 성장이 촉진되고 있습니다.

세계의 마이코플라스마 검사(Mycoplasma Testing) 시장을 조사했으며, 시장 개요, 제품·최종사용자·지역별 시장 규모 추이 및 예측, 시장 동향, 시장 성장 촉진요인 및 과제 분석, 경쟁 상황, 주요 기업 프로파일 등의 종합적인 정보를 제공합니다.

목차

개요

시장 상황

시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모
  • 시장 전망

Five Forces 분석

시장 세분화 : 제품별

  • 시장 세분화 : 제품별
  • 시장 비교 : 제품별
  • 소모품
  • 시스템
  • 시장 기회 : 제품별

시장 세분화 : 최종사용자별

  • 시장 세분화 : 최종사용자별
  • 시장 비교 : 최종사용자별
  • 임상시험 수탁기관(CRO)
  • 학술연구기관
  • 세포은행
  • 기타
  • 시장 기회 : 최종사용자별

고객 상황

시장 세분화 : 지역별

  • 시장 세분화 : 지역별
  • 시장 비교 : 지역별
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 주요 국가
  • 시장 기회 : 지역별
  • 수량 증가 - 수요 중심 성장
  • 시장의 과제
  • 시장 동향

벤더 상황

  • 개요
  • 벤더 상황
  • 파괴적 혁신 상황

벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Agilent Technologies Inc.
  • ATCC
  • Charles River Laboratories International Inc.
  • F. Hoffmann-La Roche Ltd.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Thermo Fisher Scientific Inc.

부록

LSH 20.05.14

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Technavio has been monitoring the mycoplasma testing market and it is poised to grow by $ 445.57 million during 2020-2024 progressing at a CAGR of 11% during the forecast period. Our reports on mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing focus on R&D of biopharmaceuticals, increasing initiatives and funding for mycoplasma testing and rise in adoption of real-time mycoplasma testing. In addition, increasing focus on R&D of biopharmaceuticals is anticipated to boost the growth of the market as well.

The mycoplasma testing market analysis includes end-user segment and geographic landscapes

Technavio's ‘ mycoplasma testing market ’ is segmented as below:

By End-user:

  • Pharmaceutical and biotechnology companies
  • Cros
  • Cell banks
  • Academic research institutes
  • Others

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, increasing healthcare expenditure and technological advances will lead to sizable demand in the market.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our mycoplasma testing market covers the following areas:

  • Mycoplasma testing market sizing
  • Mycoplasma testing market forecast
  • Mycoplasma testing market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Becton, Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Force Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Consumables - Market size and forecast 2019-2024
  • Systems - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user

  • Pharmaceutical and biotechnology companies
  • CROs
  • Academic research institutes
  • Cell banks
  • Others

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • ATCC
  • Charles River Laboratories International Inc.
  • F. Hoffmann-La Roche Ltd.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Consumables - Market size and forecast 2019-2024 ($ million)
  • 24: Consumables - Year-over-year growth 2019-2024 (%)
  • 25: Systems - Market size and forecast 2019-2024 ($ million)
  • 26: Systems - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Agilent Technologies Inc. - Overview
  • 48: Agilent Technologies Inc. - Business segments
  • 49: Agilent Technologies Inc. - Key offerings
  • 50: Agilent Technologies Inc. - Key customers
  • 51: Agilent Technologies Inc. - Segment focus
  • 52: ATCC - Overview
  • 53: ATCC - Product and service
  • 54: ATCC - Key offerings
  • 55: ATCC - Key customers
  • 56: ATCC - Segment focus
  • 57: Becton, Dickinson and Co. - Overview
  • 58: Becton, Dickinson and Co. - Business segments
  • 59: Becton, Dickinson and Co. - Key offerings
  • 60: Becton, Dickinson and Co. - Key customers
  • 61: Becton, Dickinson and Co. - Segment focus
  • 62: Charles River Laboratories International Inc. - Overview
  • 63: Charles River Laboratories International Inc. - Product and service
  • 64: Charles River Laboratories International Inc. - Key offerings
  • 65: Charles River Laboratories International Inc. - Key customers
  • 66: Charles River Laboratories International Inc. - Segment focus
  • 67: F. Hoffmann-La Roche Ltd. - Overview
  • 68: F. Hoffmann-La Roche Ltd. - Business segments
  • 69: F. Hoffmann-La Roche Ltd. - Key offerings
  • 70: F. Hoffmann-La Roche Ltd. - Key customers
  • 71: F. Hoffmann-La Roche Ltd. - Segment focus
  • 72: InvivoGen - Overview
  • 73: InvivoGen - Business segments
  • 74: InvivoGen - Key offerings
  • 75: InvivoGen - Key customers
  • 76: InvivoGen - Segment focus
  • 77: Lonza Group Ltd. - Overview
  • 78: Lonza Group Ltd. - Business segments
  • 79: Lonza Group Ltd. - Key offerings
  • 80: Lonza Group Ltd. - Key customers
  • 81: Lonza Group Ltd. - Segment focus
  • 82: Merck KGaA - Overview
  • 83: Merck KGaA - Business segments
  • 84: Merck KGaA - Key offerings
  • 85: Merck KGaA - Key customers
  • 86: Merck KGaA - Segment focus
  • 87: Norgen Biotek Corp. - Overview
  • 88: Norgen Biotek Corp. - Product and service
  • 89: Norgen Biotek Corp. - Key offerings
  • 90: Norgen Biotek Corp. - Key customers
  • 91: Norgen Biotek Corp. - Segment focus
  • 92: Thermo Fisher Scientific Inc. - Overview
  • 93: Thermo Fisher Scientific Inc. - Business segments
  • 94: Thermo Fisher Scientific Inc. - Key offerings
  • 95: Thermo Fisher Scientific Inc. - Key customers
  • 96: Thermo Fisher Scientific Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top
전화 문의
F A Q